To validate the safety and anti-tumor efficacy of B7-H3 CAR-T cells against metastatic CRC in vivo, we established xenograft models by intravenously injecting luciferase-expressing CRC cells (HT29 and HCT116). The gene discussed is CD276; the disease is colorectal carcinoma.